Experts slam U.S. for buying nearly all remdesivir supply

“The buying-up of remdesivir is disappointing news, not necessarily because of the shortages it implies for other countries, but because it so clearly signals an unwillingness to co-operate with other countries, and the chilling effect this has on international agreements about intellectual property rights,” Ohid Yaqub, a senior lecturer on the University of Sussex in England, stated in a press release Wednesday.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *